Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments... Show more
SNY is expected to report earnings to fall 30.60% to 90 cents per share on April 24
Q1'25
Est.
$0.91
Q4'24
Beat
by $0.53
Q3'24
Beat
by $0.88
Q2'24
Beat
by $0.84
Q1'24
Beat
by $0.85
The last earnings report on January 30 showed earnings per share of $1.31, beating the estimate of 77 cents. With 101.78K shares outstanding, the current market capitalization sits at 122.61B.